These data suggest that, in contrast to ovarian cancer models (Bizzaro et al, 2021), VEGFR2-induced angiogenesis does not appear to be a critical component of the growth and survival of PARPi-resistant breast cancer models. The gene discussed is KDR; the disease is breast carcinoma.